Dapagliflozin improves both fasting and post-prandial plasma glucose levels by reducing renal glucose reabsorption leading to urinary glucose excretion. This ...SkiptomaincontentForxiga10mgfilm-coatedtabletsBacktotopAstraZenecaUKLimitedcontactdetailsActiveingredientdapagliflozinpropanediolmonohydrateLegalCategoryPOM:PrescriptiononlymedicineATCcodeA10BK01FindsimilarproductsReportSideEffectRelatedMedicinesSameactiveingredientsSamecompanyBookmarkEmailLastupdatedonemc:10Nov2021ViewchangesPrintShowtableofcontentsHidetableofcontents1.Nameofthemedicinalproduct2.Qualitativeandquantitativecomposition3.Pharmaceuticalform4.Clinicalparticulars4.1Therapeuticindications4.2Posologyandmethodofadministration4.3Contraindications4.4Specialwarningsandprecautionsforuse4.5Interactionwithothermedicinalproductsandotherformsofinteraction4.6Fertility,pregnancyandlactation4.7Effectsonabilitytodriveandusemachines4.8Undesirableeffects4.9Overdose5.Pharmacologicalproperties5.1Pharmacodynamicproperties5.2Pharmacokineticproperties5.3Preclinicalsafetydata6.Pharmaceuticalparticulars6.1Listofexcipients6.2Incompatibilities6.3Shelflife6.4Specialprecautionsforstorage6.5Natureandcontentsofcontainer6.6Specialprecautionsfordisposalandotherhandling7.Marketingauthorisationholder8.Marketingauthorisationnumber(s)9.Dateoffirstauthorisation/renewaloftheauthorisation10.DateofrevisionofthetextThisinformationisintendedforusebyhealthprofessionals1.NameofthemedicinalproductForxiga10mgfilm-coatedtablets2.QualitativeandquantitativecompositionEachtabletcontainsdapagliflozinpropanediolmonohydrateequivalentto10mgdapagliflozin.ExcipientwithknowneffectEach10mgtabletcontains50mgoflactose.Forthefulllistofexcipients,seesection6.1.3.PharmaceuticalformFilm-coatedtablet(tablet).Yellow,biconvex,approximately1.1x0.8cmdiagonallydiamond-shaped,film-coatedtabletswith“10”engravedononesideand“1428”engravedontheotherside.4.Clinicalparticulars4.1TherapeuticindicationsType2diabetesmellitusForxigaisindicatedinadultsforthetreatmentofinsuffici